{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T20:35:11Z","timestamp":1771101311751,"version":"3.50.1"},"reference-count":54,"publisher":"MIT Press - Journals","issue":"7","content-domain":{"domain":["direct.mit.edu"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Dopamine agonists can impair inhibitory control and cause impulse control disorders for those with Parkinson disease (PD), although mechanistically this is not well understood. In this study, we hypothesized that the extent of such drug effects on impulse control is related to specific dopamine gene polymorphisms. This double-blind, placebo-controlled study aimed to examine the effect of single doses of 0.5 and 1.0 mg of the dopamine agonist ropinirole on impulse control in healthy adults of typical age for PD onset. Impulse control was measured by stop signal RT on a response inhibition task and by an index of impulsive decision-making on the Balloon Analogue Risk Task. A dopamine genetic risk score quantified basal dopamine neurotransmission from the influence of five genes: catechol-O-methyltransferase, dopamine transporter, and those encoding receptors D1, D2, and D3. With placebo, impulse control was better for the high versus low genetic risk score groups. Ropinirole modulated impulse control in a manner dependent on genetic risk score. For the lower score group, both doses improved response inhibition (decreased stop signal RT) whereas the lower dose reduced impulsiveness in decision-making. Conversely, the higher score group showed a trend for worsened response inhibition on the lower dose whereas both doses increased impulsiveness in decision-making. The implications of the present findings are that genotyping can be used to predict impulse control and whether it will improve or worsen with the administration of dopamine agonists.<\/jats:p>","DOI":"10.1162\/jocn_a_00946","type":"journal-article","created":{"date-parts":[[2016,3,4]],"date-time":"2016-03-04T15:44:00Z","timestamp":1457106240000},"page":"909-919","update-policy":"https:\/\/doi.org\/10.1162\/mitpressjournals.corrections.policy","source":"Crossref","is-referenced-by-count":35,"title":["Dopamine Gene Profiling to Predict Impulse Control and Effects of Dopamine Agonist Ropinirole"],"prefix":"10.1162","volume":"28","author":[{"given":"Hayley J.","family":"MacDonald","sequence":"first","affiliation":[{"name":"1University of Auckland"}]},{"given":"Cathy M.","family":"Stinear","sequence":"additional","affiliation":[{"name":"1University of Auckland"}]},{"given":"April","family":"Ren","sequence":"additional","affiliation":[{"name":"1University of Auckland"}]},{"given":"James P.","family":"Coxon","sequence":"additional","affiliation":[{"name":"2Monash University, Melbourne, Australia"}]},{"given":"Justin","family":"Kao","sequence":"additional","affiliation":[{"name":"3Auckland District Health Board"}]},{"given":"Lorraine","family":"Macdonald","sequence":"additional","affiliation":[{"name":"3Auckland District Health Board"}]},{"given":"Barry","family":"Snow","sequence":"additional","affiliation":[{"name":"3Auckland District Health Board"}]},{"given":"Steven C.","family":"Cramer","sequence":"additional","affiliation":[{"name":"4University of California, Irvine"}]},{"given":"Winston D.","family":"Byblow","sequence":"additional","affiliation":[{"name":"1University of Auckland"}]}],"member":"281","published-online":{"date-parts":[[2016,7,1]]},"reference":[{"key":"2021073021015333300_R1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2125.1989.tb03524.x","article-title":"A dose rising study of the safety and effects on serum prolactin of sk&f 101468, a novel dopamine d2-receptor agonist","volume":"28","author":"Acton","year":"1989","journal-title":"British Journal of Clinical Pharmacology"},{"key":"2021073021015333300_R2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1037\/a0036837","article-title":"Modeling behavioral reactivity to losses and rewards on the Balloon Analogue Risk Task (BART): Moderation by alcohol problem severity","volume":"22","author":"Ashenhurst","year":"2014","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"2021073021015333300_R3","volume-title":"Manual for the Beck Depression Inventory-II","author":"Beck","year":"1996"},{"key":"2021073021015333300_R4","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1046\/j.1365-2125.1998.t01-1-00704.x","article-title":"Effect of food on the pharmacokinetics of ropinirole in parkinsonian patients","volume":"45","author":"Brefel","year":"1998","journal-title":"British Journal of Clinical Pharmacology"},{"key":"2021073021015333300_R5","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/jnnp.68.6.685","article-title":"Dopamine agonists: Their role in the treatment of Parkinson's disease","volume":"68","author":"Brooks","year":"2000","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"2021073021015333300_R6","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/sj.bjp.0702673","article-title":"Comparison of the functional potencies of ropinirole and other dopamine receptor agonists at human d2(long), d3 and d4.4 receptors expressed in Chinese hamster ovary cells","volume":"127","author":"Coldwell","year":"1999","journal-title":"British Journal of Pharmacology"},{"key":"2021073021015333300_R7","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.neuroscience.2010.07.050","article-title":"Genetic markers of striatal dopamine predict individual differences in dysfunctional, but not functional impulsivity","volume":"170","author":"Colzato","year":"2010","journal-title":"Neuroscience"},{"key":"2021073021015333300_R8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/sj.mp.4000207","article-title":"Studies of the potential role of the dopamine d1 receptor gene in addictive behaviors","volume":"2","author":"Comings","year":"1997","journal-title":"Molecular Psychiatry"},{"key":"2021073021015333300_R9","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.biopsycho.2009.03.005","article-title":"Influence of slc6a3 and comt variation on neural activation during response inhibition","volume":"81","author":"Congdon","year":"2009","journal-title":"Biological Psychology"},{"key":"2021073021015333300_R10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/ajmg.b.30557","article-title":"Analysis of drd4 and dat polymorphisms and behavioral inhibition in healthy adults: Implications for impulsivity","volume":"147B","author":"Congdon","year":"2008","journal-title":"American Journal of Medical Genetics Part B: Neuropsychiatric Genetics"},{"key":"2021073021015333300_R11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neubiorev.2005.03.024","article-title":"Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease","volume":"30","author":"Cools","year":"2006","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"2021073021015333300_R12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neuroimage.2014.12.070","article-title":"Striatal d1 and d2 signaling differentially predict learning from positive and negative outcomes","volume":"109","author":"Cox","year":"2015","journal-title":"Neuroimage"},{"key":"2021073021015333300_R13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/cercor\/bhu165","article-title":"Functional brain activation associated with inhibitory control deficits in older adults","volume":"26","author":"Coxon","year":"2016","journal-title":"Cerebral Cortex"},{"key":"2021073021015333300_R14","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1152\/jn.01284.2006","article-title":"Selective inhibition of movement","volume":"97","author":"Coxon","year":"2007","journal-title":"Journal of Neurophysiology"},{"key":"2021073021015333300_R15","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1162\/jocn.2009.21081","article-title":"Stop and go: The neural basis of selective movement prevention","volume":"21","author":"Coxon","year":"2009","journal-title":"Journal of Cognitive Neuroscience"},{"key":"2021073021015333300_R16","doi-asserted-by":"crossref","first-page":"8401","DOI":"10.1523\/JNEUROSCI.6360-11.2012","article-title":"Aging and inhibitory control of action: Cortico-subthalamic connection strength predicts stopping performance","volume":"32","author":"Coxon","year":"2012","journal-title":"Journal of Neuroscience"},{"key":"2021073021015333300_R17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1176\/appi.ajp.161.1.125","article-title":"Genetic and neurochemical modulation of prefrontal cognitive functions in children","volume":"161","author":"Diamond","year":"2004","journal-title":"American Journal of Psychiatry"},{"key":"2021073021015333300_R18","doi-asserted-by":"crossref","first-page":"7349","DOI":"10.1523\/JNEUROSCI.6182-10.2011","article-title":"Contrasting roles for dopamine d1 and d2 receptor subtypes in the dorsomedial striatum but not the nucleus accumbens core during behavioral inhibition in the stop-signal task in rats","volume":"31","author":"Eagle","year":"2011","journal-title":"Journal of Neuroscience"},{"key":"2021073021015333300_R19","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.biopsych.2011.12.023","article-title":"Comt val 158met genotype determines the direction of cognitive effects produced by catechol-O-methyltransferase inhibition","volume":"71","author":"Farrell","year":"2012","journal-title":"Biological Psychiatry"},{"key":"2021073021015333300_R20","doi-asserted-by":"crossref","first-page":"16311","DOI":"10.1073\/pnas.0706111104","article-title":"Genetic triple dissociation reveals multiple roles for dopamine in reinforcement learning","volume":"104","author":"Frank","year":"2007","journal-title":"Proceedings of the National Academy of Sciences, U.S.A."},{"key":"2021073021015333300_R21","doi-asserted-by":"crossref","DOI":"10.1002\/0471142905.hg0212s60","article-title":"SNP genotyping using the sequenom massarray iplex platform","author":"Gabriel","year":"2009","journal-title":"Current Protocols in Human Genetics"},{"key":"2021073021015333300_R22","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.2147780","article-title":"D1 and d2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons","volume":"250","author":"Gerfen","year":"1990","journal-title":"Science"},{"key":"2021073021015333300_R23","doi-asserted-by":"crossref","first-page":"7316","DOI":"10.1523\/JNEUROSCI.4284-11.2012","article-title":"Striatal dopamine d(2)\/d(3) receptors mediate response inhibition and related activity in frontostriatal neural circuitry in humans","volume":"32","author":"Ghahremani","year":"2012","journal-title":"Journal of Neuroscience"},{"key":"2021073021015333300_R24","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nn1471","article-title":"Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior","volume":"8","author":"Goto","year":"2005","journal-title":"Nature Neuroscience"},{"key":"2021073021015333300_R25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0893-133X(98)00066-9","article-title":"Distribution of dopamine d3 receptor expressing neurons in the human forebrain: Comparison with d2 receptor expressing neurons","volume":"20","author":"Gurevich","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"2021073021015333300_R26","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1037\/a0017840","article-title":"Evaluation of genetic variability in the dopamine receptor d2 in relation to behavioral inhibition and impulsivity\/sensation seeking: An exploratory study with d-amphetamine in healthy participants","volume":"17","author":"Hamidovic","year":"2009","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"2021073021015333300_R27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0893-133X(99)00099-8","article-title":"Genotype influences in vivo dopamine transporter availability in human striatum","volume":"22","author":"Heinz","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"2021073021015333300_R28","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/mds.22678","article-title":"Association of drd3 and grin2b with impulse control and related behaviors in Parkinson's disease","volume":"24","author":"Lee","year":"2009","journal-title":"Movement Disorders"},{"key":"2021073021015333300_R29","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1037\/0033-295X.91.3.295","article-title":"On the ability to inhibit thought and action: A theory of an act of control","volume":"91","author":"Logan","year":"1984","journal-title":"Psychological Review"},{"key":"2021073021015333300_R30","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1152\/jn.00366.2014","article-title":"The fall and rise of corticomotor excitability with cancellation and reinitiation of prepared action","volume":"112","author":"MacDonald","year":"2014","journal-title":"Journal of Neurophysiology"},{"key":"2021073021015333300_R31","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1152\/jn.01184.2011","article-title":"Uncoupling response inhibition","volume":"108","author":"MacDonald","year":"2012","journal-title":"Journal of Neurophysiology"},{"key":"2021073021015333300_R32","doi-asserted-by":"crossref","first-page":"e39135","DOI":"10.1371\/journal.pone.0039135","article-title":"Dat1 polymorphism is associated with risk taking in the Balloon Analogue Risk Task (BART)","volume":"7","author":"Mata","year":"2012","journal-title":"PLoS One"},{"key":"2021073021015333300_R33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2165\/00003495-200060010-00007","article-title":"Ropinirole: A review of its use in the management of Parkinson's disease","volume":"60","author":"Matheson","year":"2000","journal-title":"Drugs"},{"key":"2021073021015333300_R34","doi-asserted-by":"crossref","first-page":"6124","DOI":"10.1523\/JNEUROSCI.0728-09.2009","article-title":"Dose-dependent inverted u-shaped effect of dopamine (d2-like) receptor activation on focal and nonfocal plasticity in humans","volume":"29","author":"Monte-Silva","year":"2009","journal-title":"Journal of Neuroscience"},{"key":"2021073021015333300_R35","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1162\/jocn_a_00327","article-title":"Dopamine d2 receptor modulation of human response inhibition and error awareness","volume":"25","author":"Nandam","year":"2013","journal-title":"Journal of Cognitive Neuroscience"},{"key":"2021073021015333300_R36","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.neubiorev.2011.04.002","article-title":"Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood","volume":"35","author":"Nemoda","year":"2011","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"2021073021015333300_R37","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.tips.2008.01.002","article-title":"The neuropharmacology of impulsive behaviour","volume":"29","author":"Pattij","year":"2008","journal-title":"Trends in Pharmacological Sciences"},{"key":"2021073021015333300_R38","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1","article-title":"Factor structure of the Barratt Impulsiveness Scale","volume":"51","author":"Patton","year":"1995","journal-title":"Journal of Clinical Psychology"},{"key":"2021073021015333300_R39","doi-asserted-by":"crossref","first-page":"e93772","DOI":"10.1371\/journal.pone.0093772","article-title":"Dopamine genetic risk score predicts depressive symptoms in healthy adults and adults with depression","volume":"9","author":"Pearson-Fuhrhop","year":"2014","journal-title":"PLoS One"},{"key":"2021073021015333300_R40","doi-asserted-by":"crossref","first-page":"e61197","DOI":"10.1371\/journal.pone.0061197","article-title":"Genetic variation in the human brain dopamine system influences motor learning and its modulation by L-DOPA","volume":"8","author":"Pearson-Fuhrhop","year":"2013","journal-title":"PLoS One"},{"key":"2021073021015333300_R41","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0014-2999(98)00896-6","article-title":"Functional potencies of new antiparkinsonian drugs at recombinant human dopamine d1, d2 and d3 receptors","volume":"366","author":"Perachon","year":"1999","journal-title":"European Journal of Pharmacology"},{"key":"2021073021015333300_R42","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00213-007-0957-y","article-title":"Single dose of a dopamine agonist impairs reinforcement learning in humans: Behavioral evidence from a laboratory-based measure of reward responsiveness","volume":"196","author":"Pizzagalli","year":"2008","journal-title":"Psychopharmacology"},{"key":"2021073021015333300_R43","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1007\/s00415-012-6506-6","article-title":"Impulse control disorders in Parkinson's disease: The role of personality and cognitive status","volume":"259","author":"Poletti","year":"2012","journal-title":"Journal of Neurology"},{"key":"2021073021015333300_R44","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.neuro.051508.135535","article-title":"The neuropsychopharmacology of fronto-executive function: Monoaminergic modulation","volume":"32","author":"Robbins","year":"2009","journal-title":"Annual Review of Neuroscience"},{"key":"2021073021015333300_R45","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/brain\/awn054","article-title":"Cognitive deficits and striato-frontal dopamine release in Parkinson's disease","volume":"131","author":"Sawamoto","year":"2008","journal-title":"Brain"},{"key":"2021073021015333300_R46","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0896-6273(02)00967-4","article-title":"Getting formal with dopamine and reward","volume":"36","author":"Schultz","year":"2002","journal-title":"Neuron"},{"key":"2021073021015333300_R47","doi-asserted-by":"crossref","first-page":"6579","DOI":"10.1523\/JNEUROSCI.16-20-06579.1996","article-title":"Coordinated expression of dopamine receptors in neostriatal medium spiny neurons","volume":"16","author":"Surmeier","year":"1996","journal-title":"Journal of Neuroscience"},{"key":"2021073021015333300_R48","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1517\/13543784.12.11.1803","article-title":"Dopamine agonists in Parkinson's disease","volume":"12","author":"Tintner","year":"2003","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"2021073021015333300_R49","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/mds.25687","article-title":"Dopamine overdose hypothesis: Evidence and clinical implications","volume":"28","author":"Vaillancourt","year":"2013","journal-title":"Movement Disorders"},{"key":"2021073021015333300_R50","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2156-6-55","article-title":"The variable number of tandem repeats element in dat1 regulates in vitro dopamine transporter density","volume":"6","author":"VanNess","year":"2005","journal-title":"BMC Genetics"},{"key":"2021073021015333300_R51","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1177\/0956797612457390","article-title":"Fictitious inhibitory differences: How skewness and slowing distort the estimation of stopping latencies","volume":"24","author":"Verbruggen","year":"2013","journal-title":"Psychological Science"},{"key":"2021073021015333300_R52","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1016\/S1353-8020(09)70794-1","article-title":"Impulse control disorders in Parkinson's disease: Prevalence and possible risk factors","volume":"15(Suppl. 3)","author":"Weintraub","year":"2009","journal-title":"Parkinsonism & Related Disorders"},{"key":"2021073021015333300_R53","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","article-title":"Impulse control disorders in Parkinson disease: A cross-sectional study of 3090 patients","volume":"67","author":"Weintraub","year":"2010","journal-title":"Archives of Neurology"},{"key":"2021073021015333300_R54","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1212\/WNL.0b013e31827b915c","article-title":"Screening for impulse control symptoms in patients with de novo Parkinson disease: A case-control study","volume":"80","author":"Weintraub","year":"2013","journal-title":"Neurology"}],"container-title":["Journal of Cognitive Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/direct.mit.edu\/jocn\/article-pdf\/28\/7\/909\/1951500\/jocn_a_00946.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/direct.mit.edu\/jocn\/article-pdf\/28\/7\/909\/1951500\/jocn_a_00946.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T01:35:48Z","timestamp":1627695348000},"score":1,"resource":{"primary":{"URL":"https:\/\/direct.mit.edu\/jocn\/article\/28\/7\/909\/28519\/Dopamine-Gene-Profiling-to-Predict-Impulse-Control"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,1]]},"references-count":54,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2016,7,1]]},"published-print":{"date-parts":[[2016,7,1]]}},"URL":"https:\/\/doi.org\/10.1162\/jocn_a_00946","relation":{},"ISSN":["0898-929X","1530-8898"],"issn-type":[{"value":"0898-929X","type":"print"},{"value":"1530-8898","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,7]]},"published":{"date-parts":[[2016,7,1]]}}}